How Decentralized Trials Combat Unconscious Bias And Reach More Diverse Patient Groups

One of the biggest challenges in clinical trials is recruitment, as the process involves gathering a sufficiently diverse patient cohort to provide high-quality, representative results. And, contrary to what most people think, it’s not just members of minority groups that are underrepresented in clinical trials. Patients who live outside of urban centers and the elderly tend to be marginalized as well.

James J. Gillespie and Joseph P. Gaspero of the Center for Healthcare Innovation once identified three reasons clinical trials need diverse participants:

• To provide more data on effective, efficient, and safe medical treatments.
• To build public confidence in clinical trial recruiting and data processes.
• To reduce health disparities, particularly in the creation and distribution of treatments for rare diseases when few or no alternatives may be available.

Discover how decentralized trials can help reduce the impact of unconscious bias, allowing researchers to diversify enrollment and build a more reliable data set.